OM
Opaleye Management’s 4D Molecular Therapeutics FDMT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-345,750
| Closed | -$7.26M | – | 47 |
|
|
2024
Q2 | $7.26M | Buy |
345,750
+1,627
| +0.5% | +$34.2K | 1.66% | 18 |
|
|
2024
Q1 | $11M | Buy |
344,123
+35,623
| +12% | +$1.13M | 2.39% | 12 |
|
|
2023
Q4 | $6.25M | Hold |
308,500
| – | – | 1.66% | 17 |
|
|
2023
Q3 | $3.93M | Buy |
308,500
+86,800
| +39% | +$1.1M | 1.28% | 22 |
|
|
2023
Q2 | $4.01M | Sell |
221,700
-92,300
| -29% | -$1.67M | 0.96% | 29 |
|
|
2023
Q1 | $5.4M | Sell |
314,000
-16,000
| -5% | -$275K | 1.62% | 18 |
|
|
2022
Q4 | $7.33M | Sell |
330,000
-20,700
| -6% | -$460K | 2.55% | 10 |
|
|
2022
Q3 | $2.82M | Buy |
350,700
+25,700
| +8% | +$207K | 1.16% | 22 |
|
|
2022
Q2 | $2.27M | Hold |
325,000
| – | – | 1.02% | 26 |
|
|
2022
Q1 | $4.91M | Buy |
325,000
+96,000
| +42% | +$1.45M | 1.53% | 22 |
|
|
2021
Q4 | $5.02M | Buy |
+229,000
| New | +$5.02M | 1.07% | 30 |
|